Admedus welcomes new opportunities in Emerging Markets

September 13, 2018

Admedus Limited (ASX:AHZ), is pleased to announce recent developments in the Emerging Markets with the introduction of CardioCel® to Vietnam and regulatory approval granted for CardioCel 3D® in the United Arab Emirates (UAE). Read the full News Release here.

About Admedus

Admedus is a global healthcare company that develops, commercialises and distributes next generation medical technologies and devices. Our mission is to provide patients around the world with a better quality of life through access to our leading medical solutions and products